PRAX vs. AVGO
PRAX (Praxis Precision Medicines, Inc.) and AVGO (Broadcom Inc.) are both stocks. PRAX operates in Biotechnology (Healthcare), while AVGO operates in Semiconductors (Technology). Over the past 5 years, PRAX returned 0.91%/yr vs 55.97%/yr for AVGO. At a 0.17 correlation, their price movements are largely independent.
Performance
PRAX vs. AVGO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PRAX achieves a 2.93% return, which is significantly lower than AVGO's 13.72% return.
PRAX
- 1D
- 7.47%
- 1M
- -11.69%
- YTD
- 2.93%
- 6M
- 8.20%
- 1Y
- 616.56%
- 3Y*
- 160.82%
- 5Y*
- 0.91%
- 10Y*
- —
AVGO
- 1D
- -4.52%
- 1M
- -5.16%
- YTD
- 13.72%
- 6M
- 15.27%
- 1Y
- 58.01%
- 3Y*
- 70.37%
- 5Y*
- 55.97%
- 10Y*
- 42.25%
PRAX vs. AVGO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PRAX Praxis Precision Medicines, Inc. | 2.93% | 282.98% | 245.42% | -37.59% | -87.92% | -64.19% | 112.10% |
AVGO Broadcom Inc. | 13.72% | 50.63% | 110.49% | 104.18% | -13.27% | 56.48% | 16.23% |
Correlation
The correlation between PRAX and AVGO is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Oct 16, 2020 | 0.17 |
Fundamentals
PRAX:
$8.76B
AVGO:
$1.91T
PRAX:
-$13.77
AVGO:
$6.01
PRAX:
6.22
AVGO:
21.80
PRAX:
-$92.00K
AVGO:
$75.47B
PRAX:
-$128.83M
AVGO:
$50.53B
PRAX:
-$344.68M
AVGO:
$42.03B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRAX vs. AVGO — Risk / Return Rank
PRAX
AVGO
PRAX vs. AVGO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Praxis Precision Medicines, Inc. (PRAX) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PRAX | AVGO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.87 | ||
| Sortino ratioReturn per unit of downside risk | +4.87 | ||
| Omega ratioGain probability vs. loss probability | 1.86 | 1.24 | +0.62 |
| Calmar ratioReturn relative to maximum drawdown | 17.13 | 2.03 | +15.09 |
| Martin ratioReturn relative to average drawdown | 48.37 | 4.63 | +43.74 |
Loading charts...
Drawdowns
PRAX vs. AVGO - Drawdown Comparison
The maximum PRAX drawdown since its inception was -98.67%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for PRAX and AVGO.
Loading charts...
Drawdown Indicators
| PRAX | AVGO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.67% | -48.30% | -50.37% |
Max Drawdown (1Y)Largest decline over 1 year | -36.33% | -28.67% | -7.66% |
Max Drawdown (3Y)Largest decline over 3 years | -68.64% | -41.15% | -27.49% |
Max Drawdown (5Y)Largest decline over 5 years | -96.50% | -41.15% | -55.35% |
Max Drawdown (10Y)Largest decline over 10 years | — | -48.30% | — |
Current DrawdownCurrent decline from peak | -66.40% | -18.44% | -47.96% |
Average DrawdownAverage peak-to-trough decline | -80.53% | -8.00% | -72.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.84% | 12.57% | +0.27% |
Volatility
PRAX vs. AVGO - Volatility Comparison
Praxis Precision Medicines, Inc. (PRAX) has a higher volatility of 32.66% compared to Broadcom Inc. (AVGO) at 21.58%. This indicates that PRAX's price experiences larger fluctuations and is considered to be riskier than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PRAX | AVGO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 32.66% | 21.58% | +11.08% |
Volatility (6M)Calculated over the trailing 6-month period | 48.71% | 33.32% | +15.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 199.36% | 46.48% | +152.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 127.61% | 43.61% | +84.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 123.86% | 39.64% | +84.22% |
Dividends
PRAX vs. AVGO - Dividend Comparison
PRAX has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.65%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVGO Broadcom Inc. | 0.65% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
PRAX Praxis Precision Medicines, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
PRAX vs. AVGO - Financials Comparison
This section allows you to compare key financial metrics between Praxis Precision Medicines, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PRAX and AVGO have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PRAX has higher volatility (32.66%) compared to AVGO (21.58%). In terms of maximum drawdown, PRAX dropped -98.67% vs AVGO's -48.30%.
PRAX currently has the higher Sharpe Ratio (3.13 vs 1.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PRAX and AVGO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer